Skip to content

Companies Products Drug classes Conditions Guides A–Z

Menu

Companies Products Drug classes Conditions Guides A–Z How we rate

Independent ratings of pharma & wellness companies and products. We don't sell — we evaluate.

Browse

Companies
Products
Drug classes
Conditions
Guides
Advertise with us

How we rate

Methodology
Data sources

Disclaimer

Information is for general reference only and is not medical advice. Consult a licensed professional. Some outbound links are affiliate links.

Privacy Policy
Terms of Use

© pharmaranks

companies/cipla limited

cipla limited

manufacturer

66/100(34)

Rated against independent sources·Last updated June 16, 2026·How we rate

Products (1)

abacavir, dolutegravir, lamivudine

abacavir, dolutegravir, lamivudine

Price variesView →

How we rate

methodology →

openFDA / Drugs@FDARegulatoryweight ×1.562/100· n=34

Based on a single source so far — the score is provisional and will firm up as more sources report.

Reviews

No reviews yet. Be the first to write one.

Write a review

Leave this field empty

Rating

Reviews are user opinions, not medical advice. Consult a licensed professional.